In a report released yesterday, Ryan Zimmerman from BTIG maintained a Hold rating on AxoGen (AXGN – Research Report). The company's shares closed last Wednesday at $10.46. According to TipRanks.com, Zimmerman is a 4-star analyst with an average return of 7.0% and a 44.9% success rate. Zimmerman covers the Healthcare sector, focusing on stocks such as Tactile Systems Technology, Treace Medical Concepts, and Organogenesis Holdings. Currently, the analyst consensus on AxoGen is a Strong Buy with an average price target of $20.25. See the top stocks recommended by analysts >> The company has a one-year high of $20.71 and a one-year low of $6.87.
https://www.tipranks.com/news/blurbs/axogen-axgn-gets-a-hold-rating-from-btig-2?utm_source=advfn.com&utm_medium=referral
Axogen (NASDAQ:AXGN)
Historical Stock Chart
From Sep 2022 to Oct 2022 Click Here for more Axogen Charts.
Axogen (NASDAQ:AXGN)
Historical Stock Chart
From Oct 2021 to Oct 2022 Click Here for more Axogen Charts.